| Anaerococcus octavius| Anaerococcus octavius (Murdoch et al. 1997) Ezaki et al. 2001| DSM 11663| NCTC 9810| Peptostreptococcus octavius| Peptostreptococcus octavius Murdoch et al. 1997
Normal flora: Anaerococcus species are typically part of the normal microbial community (microbiota) inhabiting various regions of the human body, including the skin, oral cavity, gastrointestinal tract, and genitourinary tract. In these environments, Anaerococcus octavius and related species may exist in harmony with the host, contributing to ecosystem stability and performing beneficial functions.
Opportunistic pathogen: While Anaerococcus species are generally considered low-virulence organisms, they have been implicated as opportunistic pathogens in certain clinical contexts. Infections associated with Anaerococcus spp. include skin and soft tissue infections, wound infections, abscesses, bacteremia, and infections of the female genital tract, among others. These infections typically occur in individuals with predisposing factors such as compromised immunity, underlying medical conditions, or invasive medical procedures.
Association with polymicrobial infections: Anaerococcus octavius and other Anaerococcus species are often found in polymicrobial infections, where multiple bacterial species coexist and interact within the same infection site. Polymicrobial infections can pose diagnostic and therapeutic challenges due to the diverse array of microorganisms involved and their potential for synergistic or antagonistic interactions.
Clinical significance: While Anaerococcus octavius is less studied compared to some other species within the Anaerococcus genus, its clinical significance is likely similar to other Anaerococcus species. In clinical microbiology, Anaerococcus octavius may be identified in culture-based diagnostic tests of clinical specimens from patients with suspected infections. The presence of Anaerococcus octavius in such specimens may provide valuable information to guide antimicrobial therapy and patient management.
Antimicrobial susceptibility: Anaerococcus octavius and related species may exhibit varying patterns of antimicrobial susceptibility, which can influence treatment decisions for infections caused by these bacteria. Like other anaerobic bacteria, Anaerococcus spp. are commonly susceptible to certain antibiotics such as beta-lactams (e.g., penicillins, cephalosporins), metronidazole, clindamycin, and carbapenems. However, resistance to some antimicrobial agents, including clindamycin and fluoroquinolones, has been reported among anaerobic bacteria, highlighting the importance of antimicrobial stewardship and susceptibility testing.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.04 | 0 | 154 | 154 | 154 | 154 | 154 | 0 %ile | 99 %ile | |||||
biomesight | 6.24 | 0 | 0 | 10 | 1650 | 0 | 548 | 102.9 | 30 | 227.1 | 10 | 130 | 0 %ile | 100 %ile |
thryve | 15.52 | 0 | 8 | 1 | 5474 | 0 | 1688 | 268.2 | 64 | 724.2 | 0 | 369 | 0 %ile | 100 %ile |
ubiome | 16.73 | 0 | 21 | 20 | 20938 | 0 | 6250 | 843.2 | 139 | 2758.4 | 0 | 693 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 6.462 % | 0.01 % | 0.022 % | 185.0 | 2863 |
SequentiaBiotech | 2.778 % | 0.015 % | % | 1.0 | 36 |
Thryve | 14.967 % | 0.032 % | 0.095 % | 207.0 | 1383 |
uBiome | 16.667 % | 0.084 % | 0.276 % | 132.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.